Assessment of basic reproduction number (R0), spatial and temporal epidemiological determinants, and genetic characterization of SARS-CoV-2 in Bangladesh.
PMID: 33930563
2021
Infection, genetics and evolution
Result: In case of S protein, we found 20 predominant mutation sites, among which 13 were in N-terminal domain (NTD) fragment (T95I, Q14H, S13I, T75I, H49Y, N211Y, D138H, V127F, P26, G75V, S255, Y248H, and S95F).
Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York.
Abstract: The most common sets of spike mutations in this lineage (now designated as B.1.526) are L5F, T95I, D253G, E484K or S477N, D614G, and A701V.
Method: Human plasma samples were assayed for neutralization activity against lentiviruses pseudotyped with SARS-CoV-2 spike containing a 21-amino acid cytoplasmic tail deletion and either D614G or mutations corresponding to lineage B.1.526 (L5F, T95I, D253G, E484K, D614G, and A701V).
R
Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
PMID: 33882219
2021
The New England journal of medicine
Abstract: Viral sequencing revealed variants of likely clinical importance, including E484K in 1 woman and three mutations (T95I, del142-144, and D614G) in both.
Discussion: Some of the substitutions in Patient 1 (T95I, del144, E484K, A570D, D614G, P681H, and D796H) were shared with B.1.526 (T95I, E484K, and D614G), and three substitutions were shared with Patient 2 (in whom the variants T95I, G142V and del144, F220I, R190T,
Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.
Introduction: Nearly all of the newly identified B.1.526 variants have a set of common mutations in the spike protein: L5F, T95I, D253G, E484K, D614G, and A701V.
Variant analysis of SARS-CoV-2 genomes in the Middle East.
SARS_CoV_2 mutation literature information.
PMID: 
2021
Infection, genetics and evolution
Browser Board
Co-occurred Entities
Filtrator
ViMRT